Par Pharmaceutical Begins Shipment of Generic Atacand HCT

News | 05 December 2012

• Print This

5, 2012 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that its Par Pharmaceutical, Inc. operating subsidiary has entered into an exclusive U.S. supply and distribution agreement with AstraZeneca to distribute the authorized generic ...

Click on the link to read the full article at International Business Times (press release)
(This link will open in a new window)